Targeted drug delivery in cancer typically focuses on maximising the endocytosis of drugs
into the diseased cells. However, there has been less focus on exploiting the differences in …

Humans are exposed to nanoscopical nanobiovectors (eg coronavirus SARS-CoV-2) as
well as abiotic metal/carbon-based nanomaterials that enter cells serendipitously or …

Nanoparticle size plays a central role in determining material properties and performance in
biomedical applications. A wide variety of functional nanomaterials and nano-bioconjugates …

Cell nucleus is the desired subcellular organelle of many therapeutic drugs. Although
numerous nanomaterial-based methods have been developed which could facilitate nuclear …

Although subcellular targeting can enhance the therapeutic performance of most drugs,
such targeting requires appropriate carrier-based delivery that can bypass …

Pathological ocular neovascularization resulting from retinal ischemia constitutes a major
cause of vision loss. Current anti‐VEGF therapies rely on burdensome intravitreal injections …

Conspectus Nanoparticles are widely used in various biomedical applications as drug
delivery carriers, imaging probes, single-molecule tracking/detection probes, artificial …

Anthropogenic ultrafine particulate matter (UFPM) and industrial and natural nanoparticles
(NPs) are ubiquitous. Normal term, preeclamptic, and postconceptional weeks (PCW) 8–15 …

In the view of their ability to be uptaken by cells, colloidal particles can exert diverse
physiological effects and are promising vehicles for the intracellular delivery of biologically …

Nonendocytic cell uptake of nanomaterials is challenging, which requires specific surface
chemistry and smaller particle size. Earlier works have shown that an arginine-terminated …